Webinars2023-01-10T05:32:11+00:00

Upcoming Webinars

Recent Webinars

An insider’s view into the preclinical development of an approved exon skipping drug

Categories: Recent Webinar|

Time: 11am - 12pm EST Date: November 3, 2022 Description: Dr. Arechavala works on developing new drugs for neuromuscular disorders. As there are not many for these rare diseases, neuromuscular disorders have been at the forefront of the clinical development of RNA based therapies. She is specialised in ...

Past Webinars

21October, 2022

Site-specific detection of mutagenic DNA damage with an artificial nucleotide

Categories: Past Webinars|

Time: 11am - 12pm EST Date: October 27, 2022 Description: Incorporating nucleotides with altered structures that are derived synthetically is a strategy that has been used widely to interrogate biological processes involving DNA. Particularly, synthetic nucleotides able to stabilize damaged over undamaged templates have been employed as probes ...

29July, 2022

Patient Advocacy and Therapeutic Development for Huntington’s Disease

Categories: Past Webinars|

Time: 11am - 12pm EST Date: August 11, 2022 Description: Dan O'Reilly, PhD, a former OTS Trainee BoD member, focuses his research on developing siRNA therapeutics for Huntington’s Disease. Join us as Dr. O'Reilly discusses patient advocacy and Huntington’s Disease research. Speaker: ...

30June, 2022

Transitioning from Trainee to Faculty – A conversation with Prof. Bethany Powell Gray

Categories: Past Webinars|

Time: 11am - 12pm EST Date: July 14, 2022 Description: Join us for an open discussion with Dr. Bethany Powell Gray, who is an Assisstant Professor at the John Hopkins University School of Medicine, where we will talk about the postdoc to faculty transition from the perspective of ...

26May, 2022

Pitfalls and Progress in the Development of Immune Stimulatory Nucleic Acids

Categories: Past Webinars|

Date: June 2, 2022 Time: 11-12 EST Speaker: Art Krieg, MD, Checkmate Pharmaceuticals Description: Art Krieg, MD, CSO at Checkmate Pharmaceuticals, focuses his research on stimulating innate immunity with immune stimulatory DNA and RNA. Join us as Dr. Krieg discusses the history of efforts to develop immune-activating DNA and ...

Go to Top